Pre‐Treatment <scp>MMP7</scp> Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients

MMP7 along with a multi-biomarker and GAP panel can predict IPF progression and mortality, with the potential for optimising management.

Authors

Institutions

Publication Details

Journal
Respirology
Published
2025-02-07
DOI
https://doi.org/10.1111/resp.14894
Citations
5
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
7.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients

Samantha Ellis, E. Haydn Walters, Yuben Moodley, Christopher Grainge et al.
5 citations
Respirology
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
7.59
article

Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients

Samantha Ellis, E. Haydn Walters, Yuben Moodley, Christopher Grainge, Nicole Goh, Darryl A. Knight, Christopher Zappala, Ian Glaspole, Tamera J. Corte, Gregory J. Keir, Dino B.A. Tan, Chantalia Tedja, Svetlana Baltic, Helen E. Jo, Paul N. Reynolds, Sally Chapman, Wendy A. Cooper, HuiJun Chih, Peter Hopkins, Roger M. Li
article en
5 citations

Abstract

MMP7 along with a multi-biomarker and GAP panel can predict IPF progression and mortality, with the potential for optimising management.

RespirologyVol. 30(6)
The University of Sydney (AU), Royal Adelaide Hospital (AU), The University of Queensland (AU), The University of Melbourne (AU), The University of Western Australia (AU), Curtin University (AU), Royal Prince Alfred Hospital (AU), Austin Hospital (AU), John Hunter Hospital (AU), Fiona Stanley Hospital (AU), The Alfred Hospital (AU), Royal Hobart Hospital (AU), Prince Charles Hospital (AU), Providence Health Care Research Institute (CA), Institute for Respiratory Health (AU), Monash University (AU), The University of Adelaide (AU), Western Sydney University (AU), University of Newcastle Australia (AU)
Boehringer Ingelheim España, Lung Foundation Australia, Medical Research Council, National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 3%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
7.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.